摘要
前列腺癌是全球男性肿瘤相关死因的第五大原因。由于其潜伏期长,这种病理表现为一种理想的疾病类型的化学预防研究。在迄今为止被用于治疗前列腺癌的药物中,天然化合物白藜芦醇非常有前景。白藜芦醇是公认的一种化学预防剂,并被证明在几种肿瘤中能增强传统化疗药物的抗肿瘤活性,其中包括前列腺癌。本文综述了近五年来有关白藜芦醇及其衍生物作为前列腺癌抗转移药物的研究进展。此外,还提出了药物联合研究和纳米医学方法,以提高白藜芦醇的活性和克服转移缺陷。综述的最后一部分讨论了正在进行的含白藜芦醇的癌症患者临床试验。
关键词: 前列腺癌,白藜芦醇,二苯乙烯,转移,临床试验,药物联合。
Current Medicinal Chemistry
Title:Resveratrol and Prostate Cancer: The Power of Phytochemicals
Volume: 28 Issue: 24
关键词: 前列腺癌,白藜芦醇,二苯乙烯,转移,临床试验,药物联合。
摘要: Prostate cancer is the fifth cause of tumor-related deaths in man worldwide. Due to its long latency period, this pathology represents an ideal type of disease for chemopreventive studies. Among the drugs considered thus far for the treatment of prostate cancer, the natural compound resveratrol emerged as very promising. Resveratrol is widely recognized as a chemopreventive agent and was shown to potentiate the antitumor activity of conventional chemotherapeutics in several tumors, including prostate cancer. Here, we overview the literature of the last five years and summarize the recent achievements of resveratrol and its derivatives as antimetastatic agents in prostate cancer. Moreover, drug combination studies as well as nanomedicine approaches proposed to improve resveratrol activity and to overcome delivery drawbacks are addressed. The last part of the review discusses the clinical trials containing resveratrol ongoing on cancer patients.
Export Options
About this article
Cite this article as:
Resveratrol and Prostate Cancer: The Power of Phytochemicals, Current Medicinal Chemistry 2021; 28 (24) . https://dx.doi.org/10.2174/0929867328666201228124038
DOI https://dx.doi.org/10.2174/0929867328666201228124038 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Intraperitoneal Chemotherapy as First-Line Treatment in the Management of Epithelial Ovarian Cancer
Mini-Reviews in Medicinal Chemistry Micro-RNA in Disease and Gene Therapy
Current Drug Discovery Technologies P-Glycoprotein, but not Multidrug Resistance Protein 4, Plays a Role in the Systemic Clearance of Irinotecan and SN-38 in Mice
Drug Metabolism Letters Pyrazole Derivatives as Antitumor, Anti-Inflammatory and Antibacterial Agents
Mini-Reviews in Medicinal Chemistry Promising Pharmacological, Molecular and Cellular Treatments of Autoimmune Hepatitis
Current Pharmaceutical Design Present Drug Therapy of Demyelinating Disorders
Current Drug Therapy Doripenem: A New Addition to the Carbapenem Class of Antimicrobials
Recent Patents on Anti-Infective Drug Discovery Angiogenesis Markers in Gynecological Tumors and Patents for Anti- Angiogenic Approach: Review
Recent Patents on Anti-Cancer Drug Discovery The Effects of Bisphosphonates on the Bone Marrow Niche and Circulating and Disseminated Tumor Cells
Current Cancer Therapy Reviews Label-Free Cell Phenotypic Assays for Assessing Drug Polypharmacology
Current Pharmaceutical Design QSAR and 3D-QSAR Models in the Field of Tubulin Inhibitors as Anticancer Agents
Current Topics in Medicinal Chemistry Vitamin D and Metabolic Syndrome: Is There a Link?
Current Pharmaceutical Design Cytochrome P450-Activated Prodrugs: Targeted Drug Delivery
Current Medicinal Chemistry Continuous Nanostructures for the Controlled Release of Drugs
Current Pharmaceutical Design Recent Trends in Nanotechnology-Based Drugs and Formulations for Targeted Therapeutic Delivery
Recent Patents on Inflammation & Allergy Drug Discovery Passive and Active Tumour Targeting with Nanocarriers
Current Drug Discovery Technologies 3D-QSAR Modeling of Non-peptide Antagonists for the Human Luteinizing Hormone-releasing Hormone Receptor
Medicinal Chemistry Episomal Vectors for Gene Therapy
Current Gene Therapy P53 Mdm2 Inhibitors
Current Pharmaceutical Design Curcumin: Not So Spicy After All
Mini-Reviews in Medicinal Chemistry